Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
about
Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study.Imaging Parkinson's disease below the neck.Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutationsPattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PETDiagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.Nonmotor features of Parkinson's disease subtypes.Imaging Systemic Dysfunction in Parkinson's Disease.2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson's Disease.Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease.Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease.Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease.Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.Differences in odor identification among clinical subtypes of Parkinson's disease.Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?
P2860
Q31080551-AA4CE5CA-6FAB-4B5D-AD04-7EC4B2F33EC9Q33585003-3BFBF857-7F32-416B-863C-190705074852Q33767061-0C03EBA3-36C9-443F-85CE-D8664A622CE5Q33790729-852508F3-BCAD-4FF5-8B47-6F28A91E5F36Q34683979-E58FF9C4-9374-40E6-9144-3528283051B2Q35004642-360554FB-3EDB-42DB-AEF8-BBB91B7F6784Q36247833-632EF603-3FB4-4162-85A2-6C1E4A6B8271Q37811053-F225E4DA-5223-4518-BD22-C354206FA9A7Q37906394-14F06574-3797-433C-A25E-1F5F2C671093Q38531996-8D1532AD-052E-4FD2-98EE-286EDC1E8866Q38727963-7612D06F-06B0-4C0C-BA1D-5CF709CAC2FAQ38807024-322076CD-6A75-484B-971D-CD1923FDDF58Q39475357-849F62A8-01E5-43B9-85B2-E2FD9F0B7FACQ42369753-416C371F-1820-4BDC-87A5-CD68A2C80A9AQ42408447-AFD01540-9628-407F-94AF-93DF24A82038Q43173986-C09D3784-4D76-439D-9D10-AEA4B13F4B73Q48147522-1E2E69F5-21CA-4732-BDA3-0168458136A0Q48196747-7BB3F38F-A65E-4AAB-9B1E-63AE468DB096Q49336936-33A7322F-C53B-410F-8EE3-D1FC93575624Q50267949-36D15584-84BC-4E3D-BC3B-F6363E1AA5FFQ51192358-BFAA6EFE-2BD5-4600-9E65-A5EC297873A6
P2860
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@en
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@nl
type
label
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@en
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@nl
prefLabel
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@en
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@nl
P2093
P1476
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
@en
P2093
Ariyuki Hori
Genjiro Hirose
Kazuo Kakeshita
Koichiro Sakai
Kotaro Higashi
Miho Miaki
Misuzu Saiki
Muichi Kaito
Satoshi Kataoka
Shinji Saiki
P304
P356
10.1016/J.JNS.2004.02.018
P577
2004-05-01T00:00:00Z